To correlate the expression of the surface markers with functional resistance, we treated naive patient BCC explants with SMOi vismodegib, and found that protein expression of all three markers is significantly correlated with maintenance of Gli1 mRNA levels, indicating diminished response to SMO inhibition ex vivo (Fig. 2i). Here, SMO is linked to skin basal cell carcinoma.